Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Obstetrics and Gynecology of India
Published in: The Journal of Obstetrics and Gynecology of India 1/2016

01-10-2016 | Original Article

Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome

Authors: Saxena Pikee, Singh Shivani, Bhattacharjee Jayshree

Published in: The Journal of Obstetrics and Gynecology of India | Special Issue 1/2016

Login to get access

Abstract

Background

Polycystic ovarian syndrome (PCOS) is a common endocrinopathy associated with wide heterogeneity and serious clinical implications. Prevalence and characteristics of different phenotypes are not well defined. Therefore, this study was planned to determine the prevalence of four phenotypes of PCOS and to evaluate their endocrine and metabolic parameters including insulin resistance and metabolic syndrome with respect to controls.

Methods

This observational, case–control study was conducted in the gynecology outpatient department of a tertiary care center where 161 PCOS and 50 non-PCOS women were recruited and investigated.

Results

All phenotypes of PCOS had higher BMI with respect to controls (P < 0.000). Overweight women were maximum in phenotype H + O followed by phenotype H + P. Significantly higher levels of luteinizing hormone (P < 0.01), testosterone (P < 0.0001), were observed in all phenotypes of PCOS as compared to controls. Serum cholesterol (P < 0.026) and triglycerides (P < 0.05) were significantly higher in all PCOS phenotypes compared to controls. Levels of fasting (P < 0.000) and post-prandial (P < 0.009) insulin were significantly higher in all phenotypes of PCOS with respect to controls. Mean insulin resistance (IR) was 24.09 % in PCOS and 2 % in controls, prevalence being highest in H + O phenotype followed by H + O + P. Prevalence of metabolic syndrome in women with PCOS was 36.02 %, being highest in H + O + P followed by H + O and that of control was 10 %.

Conclusion

All phenotypes of PCOS had deranged endocrine and metabolic profile compared to controls, but prevalence of IR and metabolic syndrome was maximum in hyperandrogenic phenotypes which require a strict surveillance for prospective metabolic disorders as compared to O + P phenotype.
Literature
1.
2.
Orio F Jr, Palomba S, Cascella T, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(1):2–5.CrossRefPubMed
3.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;30(8):41. doi:10.​1186/​1741-7015-8-41.CrossRef
4.
5.
6.
The Rotterdam ESRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovarian syndrome. Fertile Steril. 2003;81:19–25.
7.
Strauss JF. Some new thoughts on the pathophysiology and genetics of polycystic ovarian syndrome. Ann NY Acad Sci. 2003;997(1):42–8.CrossRefPubMed
8.
De Leo V, Musacchio MC, Palermo V, et al. Polycystic ovary syndrome and metabolic co-morbidities: therapeutic options. Drugs Today. 2009;45:763–75.CrossRefPubMed
9.
Zawadski JK, Dunaif A. Diagnostic criteria for polycytic ovarian syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovarian syndrome. Boston: Blackwell Scientific; 1992. p. 337–84.
10.
Redmond GP, Bergfeld WF. Diagnostic approach to androgen disorders in women: acne, hirsutism and alopecia. Clevel Clin J Med. 1990;57(5):423–7.CrossRef
11.
Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106:1317.CrossRef
12.
13.
Saxena P, Prakash A, Nigam A. Efficacy of 2-hour post glucose insulin levels in predicting insulin resistance in polycystic ovarian syndrome with infertility. J Hum Reprod Sci. 2011;4(1):20–2.CrossRefPubMedPubMedCentral
14.
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694–8.PubMed
15.
Chauhan S, Joshi B, Mukherjee S, et al. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014;18(3):317–24.CrossRefPubMedPubMedCentral
16.
17.
Welt CK, Gudmundsson JA, Arason G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006;91(12):4842–8.CrossRefPubMed
18.
Zhang HY, Zhu FF, Xiong J, et al. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009;116(12):1633–9.CrossRefPubMed
19.
Baldani DP, Skrgatić L, Simunić V, et al. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population. Coll Antropol. 2013;37(2):477–82. PubMed
20.
Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27(2):541–9. doi:10.​1093/​humrep/​der418.CrossRefPubMed
21.
Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complication in the new PCOS phenotypes based on Rotterdam criteria. Am Soc Reprod Med. 2007;88:1389–95.
Metadata
Title
Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome
Authors
Saxena Pikee
Singh Shivani
Bhattacharjee Jayshree
Publication date
01-10-2016
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue Special Issue 1/2016
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0898-7

Other articles of this Special Issue 1/2016

The Journal of Obstetrics and Gynecology of India 1/2016 Go to the issue

Original Article

Gynecological Problems of Adolescent Girls Attending Outpatient Department at Tertiary Care Center with Evaluation of Cases of Puberty Menorrhagia Requiring Hospitalization

Original Article

Screening for Postnatal Depression in a Tertiary Care Hospital

Original Article

Endometrial and Subendometrial Vascularity by Three-Dimensional (3D) Power Doppler and Its Correlation with Pregnancy Outcome in Frozen Embryo Transfer (FET) Cycles

Original Article

Evaluation of Role of GnRH Antagonist in Intrauterine Insemination (IUI) Cycles with Mild Ovarian Hyperstimulation (MOH): A Prospective Randomised Study

Original Article

A Single-Centre Experience of Obstetric Acute Kidney Injury

Original Article

Unmet Needs of Family Planning Among Women: A Cross-Sectional Study in a Rural Area of Kanchipuram District, Tamil Nadu, South India